title: Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
abstract: The ELISA we developed was able to determine the antigen content and was suitable for a potency test, and we described a relative potency assay method which determines the potency of test vaccines by comparing the ELISA value of a test vaccine to that of a reference vaccine. In the present study, we standardized the reference vaccine used for determining the potencies of test vaccines, and established a potency test by ELISA. We evaluated the proposed reference vaccine by the neutralizing antibody responses in dogs after vaccination, by the challenge protection test in guinea pigs (GP potency test), which is the earlier official potency test used in Japan, and by the NIH potency test, which is widely used throughout the world. The results showed that a 4-fold dilution of the proposed reference vaccine induced sufficient immunity in dogs. A 3-fold dilution of the proposed reference vaccine passed the GP potency test. The international units (IU) calibrated by the NIH potency test were 3.7 IU/dose. From the results and the WHO recommendation that veterinary rabies vaccines should have a potency of at least 1.0 IU/dose, we determined to dilute the proposed reference vaccine by 3 fold and regarded it as the reference vaccine. Finally, we confirmed that there is a good agreement between the results of the potency test by ELISA and the results of the GP potency test. The establishment of the potency test by ELISA has made it possible to monitor the potency in the production process and has contributed to the stable production of the vaccine.
authors.affiliation: National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, Kokubunji, Tokyo, Japan.
authors.forename: Koichiro
authors.initials: K
authors.lastname: Gamoh
authors.forename: Yohko
authors.initials: Y
authors.lastname: Shimazaki
authors.forename: Megumi
authors.initials: M
authors.lastname: Senda
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Makie
authors.forename: Osamu
authors.initials: O
authors.lastname: Itoh
authors.forename: Masatake
authors.initials: M
authors.lastname: Muramatsu
authors.forename: Norio
authors.initials: N
authors.lastname: Hirayama
authors.forename: Hideo
authors.initials: H
authors.lastname: Hatakeyama
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis* / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D004283:Dog Diseases / Q000276:immunology / Q000517:prevention & control; D004285:Dogs; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D007564:Japan; D009316:National Institutes of Health (U.S.); D009500:Neutralization Tests; D011818:Rabies / Q000276:immunology* / Q000517:prevention & control; D011819:Rabies Vaccines / Q000276:immunology*; D012016:Reference Values; D014481:United States
chemical_list: D000914:Antibodies, Viral; D000956:Antigens, Viral; D011819:Rabies Vaccines